IDEA2 2024 meeting


Imagen Noticia

Dr. Carmen Plasencia, CEO f AROMICS presents the advances of our projects at the second meeting of IDEA2 2024. AROMICS is one of the eight teams admited in the current edition organized by  the international biomedical technology innovation consortium based in the Massachusetts Institute of Technology Institute for Medical Engineering and Sciences (MIT IMES). The seven-month program provides intensive innovation method training, collaborative project development, team-specific mentoring, and expertise to help projects move from novel ideas toward real-world application. 


European Union